<?xml version="1.0" encoding="UTF-8"?>
<NDC>
<NDCCode>
63739-475-05
</NDCCode>
<PackageDescription>
5 POUCH in 1 BOX (63739-475-05) > 1 VIAL, MULTI-DOSE in 1 POUCH (63739-475-21) > 50 mL in 1 VIAL, MULTI-DOSE
</PackageDescription>
<NDC11Code>
63739-0475-05
</NDC11Code>
<ProductNDC>
63739-475
</ProductNDC>
<ProductTypeName>
HUMAN PRESCRIPTION DRUG
</ProductTypeName>
<ProprietaryName>
Lidocaine Hydrochloride And Epinephrine
</ProprietaryName>
<ProprietaryNameSuffix/>
<NonProprietaryName>
Lidocaine Hydrochloride Anhydrous And Epinephrine
</NonProprietaryName>
<DosageFormName>
INJECTION, SOLUTION
</DosageFormName>
<RouteName>
INFILTRATION
</RouteName>
<StartMarketingDate>
20100503
</StartMarketingDate>
<EndMarketingDate/>
<MarketingCategoryName>
ANDA
</MarketingCategoryName>
<ApplicationNumber>
ANDA089646
</ApplicationNumber>
<LabelerName>
McKesson Packaging Services Business Unit of McKesson Corporation
</LabelerName>
<SubstanceName>
LIDOCAINE HYDROCHLORIDE ANHYDROUS; EPINEPHRINE
</SubstanceName>
<StrengthNumber>
20; 10
</StrengthNumber>
<StrengthUnit>
mg/mL; ug/mL
</StrengthUnit>
<Pharm_Classes>
Amide Local Anesthetic [EPC],Amides [CS],Antiarrhythmic [EPC],Local Anesthesia [PE],Adrenergic alpha-Agonists [MoA],Adrenergic beta-Agonists [MoA],alpha-Adrenergic Agonist [EPC],beta-Adrenergic Agonist [EPC],Catecholamine [EPC],Catecholamines [CS]
</Pharm_Classes>
<DEASchedule/>
<Status>
Deprecated
</Status>
<LastUpdate>
2019-09-21
</LastUpdate>
<PackageNdcExcludeFlag/>
<ProductNdcExcludeFlag>
E
</ProductNdcExcludeFlag>
<ListingRecordCertifiedThrough>
20171231
</ListingRecordCertifiedThrough>
<StartMarketingDatePackage/>
<EndMarketingDatePackage/>
<SamplePackage/>
</NDC>